BICLUSTER_ID : UPREG-16
PATHOGENS /2/ : mycobacterium tuberculosis,ehrlichia chaffeensis
TARGETS /27/ : PLA2G4A, LCK, JUN, CCL2, CD40, TNFRSF1B, HCK, VCAM1, AMPD3, CCL5, TGFB1, SAT1, CD86, STAT1, ABCC1, HMOX1, MMP9, CCL8, TAP1, IL2RG, IL1B, CASP1, ICAM1, PTGER2, IL1R1, TNF, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPPFKFB3, LCK, NMI, TLR4, PMAIP1, IFI44, FOS, SP100, TNFSF10, GADD45G, SRC, LCP2, RGS1, CD53, IL1B, ICAM1, CASP1, UPP1, IL1R1, GBP1, TNFRSF1B, PSCDBP, IER3, CCL4, STAT1, KLF6, VIM, CCR1, IL2RG, NKG7, PLAUR, TNF, MX1
NETPATH KIT RECEPTOR PATHWAY UPPLA2G4A, HMOX1, MMP9, MCL1, CCL2, TAP1, IL2RG, CCL5, FOS, KITLG, TNF, IER3
NETPATH IL 1 PATHWAY UPBIRC3, MMP14, CXCL1, CCL2, NFKBIE, CCL8, NFKBIA, AMPD3, IL1B, ICAM1, CXCL2, CCL4
NETPATH IL 6 PATHWAY UPGADD45B, MCL1, JUN, HBEGF, MAP3K8, NMI, TNFRSF11B, FOS, STAT1, MMP9, ABCC1, CXCL1, CEBPD, CEBPB, JUNB, NEU3, MAFF, IRF1, PRDM1, MX1, TNF
NCI IL12 2PATHWAYSTAT1, GADD45B, GADD45G, IL2RG, IL1B, FOS, IL1R1, CCL4
SA MMP CYTOKINE CONNECTIONIL1B, CSF1, SELL, TGFB1, TNFRSF1B, TNF
NETPATH IL 3 PATHWAY UPCSF1, MCL1, CCL2, CCR1, IL1B, TGFB1, FOS, CD86, CCL4
NETPATH IL 7 PATHWAY UPFAS, CXCL1, MCL1, CCL8, CCL5, CD86, CXCL2, CCL4
NCI IL23PATHWAYNFKBIA, STAT1, IL1B, CXCL1, CCL2
GERY CEBP TARGETSRGS2, GADD45B, HMOX1, CXCL1, GADD45G, IFRD1, SAT1, FOS, PLAUR, BTG2
NETPATH IL 4 PATHWAY DOWNSTAT1, GADD45B, VIM, CD9, CCL2, TNFSF10, GBP2, NFKBIA, GEM, ICAM1, CXCL2, MX1
NETPATH IL 5 PATHWAY UPPLSCR1, TLR1, MAX, CCL2, NFKBIE, DUSP6, RELB, IER3, MYD88, EGR2, CASP4, BIRC3, HLX1, CCR1, LCP2, IL1B, ICAM1, UPP1, PRDM1
NETPATH IL 4 PATHWAY UPFGL2, CCL2, HPCAL1, TLR4, IL1RN, ARHGAP25, TFEC, FOS, CD86, EGR2, RGS2, CEBPB, MAF, RASGRP1, NKG7, IL10RA, TIMP3, PTGER2, CTSC, UPP1
NETPATH T CELL RECEPTOR PATHWAY DOWNIFITM1, NFKBIA, CASP1, TGFB1, TRIM24, CHST11, IRF7, CCR1
NCI IL6 7PATHWAYSTAT1, CEBPD, MCL1, CEBPB, LBP, HCK, PRKCD, GAB2, FOS, PTPRE
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELLVCAM1, IFITM1, TYROBP, SELL, CD40
RICKMAN METASTASIS DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION GRANULOCYTE DN
NCI BCR 5PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
RASHI RESPONSE TO IONIZING RADIATION 6
NETPATH IL 9 PATHWAY UP
WEINMANN ADAPTATION TO HYPOXIA DN
LINDGREN BLADDER CANCER CLUSTER 2B
KEGG GRAFT VERSUS HOST DISEASE
VARELA ZMPSTE24 TARGETS UP
CORUM ITGA2B-ITGB3-CD9 COMPLEX
FAELT B CLL WITH VH REARRANGEMENTS UP
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
RADAEVA RESPONSE TO IFNA1 UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
LINDSTEDT DENDRITIC CELL MATURATION D
COATES MACROPHAGE M1 VS M2 UP
VALK AML CLUSTER 1
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
JEON SMAD6 TARGETS UP
NAKAYAMA FRA2 TARGETS
MITSIADES RESPONSE TO APLIDIN UP
MORI MATURE B LYMPHOCYTE UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
KLEIN PRIMARY EFFUSION LYMPHOMA DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
CONRAD GERMLINE STEM CELL
LENAOUR DENDRITIC CELL MATURATION DN
BOYAULT LIVER CANCER SUBCLASS G56 DN
KUMAR TARGETS OF MLL AF9 FUSION
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
NCI HIF1 TFPATHWAY
XU AKT1 TARGETS 6HR
HUANG FOXA2 TARGETS UP
POOLA INVASIVE BREAST CANCER UP
SENGUPTA EBNA1 ANTICORRELATED
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
WOTTON RUNX TARGETS UP
LIU VAV3 PROSTATE CARCINOGENESIS UP
NIELSEN SYNOVIAL SARCOMA DN
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
DAUER STAT3 TARGETS DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
AMIT EGF RESPONSE 120 HELA
DANG REGULATED BY MYC DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
MCLACHLAN DENTAL CARIES UP
PARK TRETINOIN RESPONSE
PODAR RESPONSE TO ADAPHOSTIN UP
HOSHIDA LIVER CANCER SUBCLASS S1
JAATINEN HEMATOPOIETIC STEM CELL DN
KYNG DNA DAMAGE UP
LEE LIVER CANCER E2F1 UP
DAVIES MULTIPLE MYELOMA VS MGUS DN
PARK TRETINOIN RESPONSE AND RARA PLZF FUSION
HELLER SILENCED BY METHYLATION UP
ROETH TERT TARGETS DN
BOWIE RESPONSE TO TAMOXIFEN
NCI P38ALPHABETAPATHWAY
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
FINAK BREAST CANCER SDPP SIGNATURE
NETPATH IL 3 PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
STEARMAN LUNG CANCER EARLY VS LATE DN
CORUM ITGAV-ITGB8-MMP14-TGFB1 COMPLEX
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
REACTOME TOLL LIKE RECEPTOR 4 CASCADE
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
REACTOME GENERATION OF SECOND MESSENGER MOLECULES
REACTOME G ALPHA I SIGNALLING EVENTS
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC DN
SPIRA SMOKERS LUNG CANCER UP
TIAN TNF SIGNALING VIA NFKB
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
GOLUB ALL VS AML DN
LEE EARLY T LYMPHOCYTE DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE DN
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
NCI ATF2 PATHWAY
KEGG PRIMARY IMMUNODEFICIENCY
ZHANG INTERFERON RESPONSE
COLIN PILOCYTIC ASTROCYTOMA VS GLIOBLASTOMA DN
STEARMAN TUMOR FIELD EFFECT UP
CROONQUIST STROMAL STIMULATION UP
BOYLAN MULTIPLE MYELOMA D DN
KHETCHOUMIAN TRIM24 TARGETS UP
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
KIM LRRC3B TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
HORIUCHI WTAP TARGETS UP
WOO LIVER CANCER RECURRENCE UP
NETPATH B CELL RECEPTOR PATHWAY
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
DORN ADENOVIRUS INFECTION 32HR UP
BIOCARTA TH1TH2 PATHWAY
TSAI DNAJB4 TARGETS UP
MORI PRE BI LYMPHOCYTE DN
BOQUEST STEM CELL DN
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
GARY CD5 TARGETS UP
GILDEA METASTASIS
AMIT EGF RESPONSE 20 HELA
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
BASSO CD40 SIGNALING UP
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
IVANOVA HEMATOPOIESIS LATE PROGENITOR
BIOCARTA FCER1 PATHWAY
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
LINDGREN BLADDER CANCER CLUSTER 2A DN
BOYLAN MULTIPLE MYELOMA C D DN
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
MAHADEVAN RESPONSE TO MP470 UP
SMID BREAST CANCER NORMAL LIKE UP
FERRARI RESPONSE TO FENRETINIDE UP
SANA RESPONSE TO IFNG UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
REACTOME COSTIMULATION BY THE CD28 FAMILY
BOYLAN MULTIPLE MYELOMA PCA1 UP
CHEN HOXA5 TARGETS 9HR UP
SEKI INFLAMMATORY RESPONSE LPS UP
HOEBEKE LYMPHOID STEM CELL UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
MOSERLE IFNA RESPONSE
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
RODWELL AGING KIDNEY UP
REACTOME TOLL RECEPTOR CASCADES
INGA TP53 TARGETS
ODONNELL TARGETS OF MYC AND TFRC UP
KEGG CYTOSOLIC DNA SENSING PATHWAY
VALK AML CLUSTER 5
MORI IMMATURE B LYMPHOCYTE UP
REACTOME ACTIVATED TLR4 SIGNALLING
HESS TARGETS OF HOXA9 AND MEIS1 DN
CROONQUIST NRAS SIGNALING UP
BIOCARTA TOLL PATHWAY
IIZUKA RECURRENT LIVER CANCER
NCI PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
MORI SMALL PRE BII LYMPHOCYTE UP
VERHAAK AML WITH NPM1 MUTATED DN
BIOCARTA PML PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
BOYAULT LIVER CANCER SUBCLASS G5 DN
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
SWEET LUNG CANCER KRAS UP
TENEDINI MEGAKARYOCYTE MARKERS
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
CORUM ITGA2B-ITGB3-CD9-GP1B-CD47 COMPLEX
LINDSTEDT DENDRITIC CELL MATURATION A
MORI LARGE PRE BII LYMPHOCYTE DN
WATANABE ULCERATIVE COLITIS WITH CANCER DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
BIOCARTA NKT PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
WILENSKY RESPONSE TO DARAPLADIB
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN
HOFFMANN IMMATURE TO MATURE B LYMPHOCYTE UP
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
FRIDMAN IMMORTALIZATION DN
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
OSADA ASCL1 TARGETS DN
REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS
BIOCARTA LYM PATHWAY
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
PARK APL PATHOGENESIS DN
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
SEMENZA HIF1 TARGETS
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHAN V1 LATE DIFFERENTIATION GENES UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
ONDER CDH1 TARGETS 3 DN
TARTE PLASMA CELL VS B LYMPHOCYTE DN
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
BROWNE HCMV INFECTION 8HR UP
NCI CD8TCRPATHWAY
RAMALHO STEMNESS DN
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
MARKEY RB1 CHRONIC LOF DN
NCI AMB2 NEUTROPHILS PATHWAY
GESERICK TERT TARGETS DN
NOJIMA SFRP2 TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
AMIT SERUM RESPONSE 120 MCF10A
TAVOR CEBPA TARGETS DN
LEE LIVER CANCER MYC E2F1 UP
NCI IL1PATHWAY
SESTO RESPONSE TO UV C3
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINED IN MONOCYTE DN
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
BIOCARTA TCAPOPTOSIS PATHWAY
GRANDVAUX IRF3 TARGETS UP
ZHU CMV ALL UP
ROZANOV MMP14 TARGETS UP
NATSUME RESPONSE TO INTERFERON BETA UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
REACTOME TCR SIGNALING
KEGG TYPE I DIABETES MELLITUS
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
RHEIN ALL GLUCOCORTICOID THERAPY UP
CHEN HOXA5 TARGETS 6HR UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
LEONARD HYPOXIA
MARTINELLI IMMATURE NEUTROPHIL DN
CORUM ITGA2B-ITGB3-CD47-FAK COMPLEX
LEE LIVER CANCER MYC TGFA UP
NCI TOLL LIKE RECEPTOR 4 TLR4 CASCADE
LEE LIVER CANCER DENA UP
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
WALLACE PROSTATE CANCER RACE UP
SAGIV CD24 TARGETS DN
REACTOME MYD88 CASCADE
KEGG MAPK SIGNALING PATHWAY
WIELAND UP BY HBV INFECTION
COATES MACROPHAGE M1 VS M2 DN
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
EHRLICH ICF SYNDROM DN
UROSEVIC RESPONSE TO IMIQUIMOD
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
REACTOME INNATE IMMUNITY SIGNALING
WU SILENCED BY METHYLATION IN BLADDER CANCER
KAN RESPONSE TO ARSENIC TRIOXIDE
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA DN
NETPATH B CELL RECEPTOR PATHWAY DOWN
XU RESPONSE TO TRETINOIN AND NSC682994 UP
SOUCEK MYC TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
BILBAN B CLL LPL DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
IZADPANAH STEM CELL ADIPOSE VS BONE UP
CORUM ITGA2B-ITGB3-CD47-SRC COMPLEX
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
NETPATH KIT RECEPTOR PATHWAY
DER IFN ALPHA RESPONSE UP
LEE LIVER CANCER ACOX1 UP
RUTELLA RESPONSE TO HGF DN
WANG ESOPHAGUS CANCER PROGRESSION UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
DAZARD UV RESPONSE CLUSTER G2
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
ST T CELL SIGNAL TRANSDUCTION
KEGG ALLOGRAFT REJECTION
AMIT SERUM RESPONSE 40 MCF10A
DE YY1 TARGETS UP
BROWNE HCMV INFECTION 4HR UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
MARSON FOXP3 TARGETS DN
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
THUM SYSTOLIC HEART FAILURE UP
NCI IL27PATHWAY
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
REACTOME PECAM1 INTERACTIONS
ROSS AML WITH CBFB MYH11 FUSION
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
NAKAJIMA MAST CELL
CASTELLANO NRAS TARGETS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
LEE TARGETS OF PTCH1 AND SUFU DN
KEGG HEMATOPOIETIC CELL LINEAGE
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
SENESE HDAC3 TARGETS UP
NCI PI3KCIPATHWAY
LIAN LIPA TARGETS 3M
KEGG CHEMOKINE SIGNALING PATHWAY
KLEIN TARGETS OF BCR ABL1 FUSION
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
FUJII YBX1 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
JISON SICKLE CELL DISEASE UP
BAELDE DIABETIC NEPHROPATHY DN
NCI IL12 STAT4PATHWAY
CHIANG LIVER CANCER SUBCLASS INTERFERON UP
XU HGF SIGNALING NOT VIA AKT1 48HR UP
NETPATH T CELL RECEPTOR PATHWAY UP
HELLER HDAC TARGETS DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
ZHAN MULTIPLE MYELOMA HP UP
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
HOFFMANN PRE BI TO LARGE PRE BII LYMPHOCYTE DN
IVANOVA HEMATOPOIESIS MATURE CELL
OKAMOTO LIVER CANCER MULTICENTRIC OCCURRENCE UP
WATTEL AUTONOMOUS THYROID ADENOMA DN
FERRANDO T ALL WITH MLL ENL FUSION UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis wakullamycobacterium tuberculosisehrlichia chaffeensis libertyGeneSet Name
0.00006 0.00008 0.01786NETPATH_IL_2_PATHWAY_UP
0.00015 0.00019 0.05936NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00022 0.00602 0.04640NETPATH_IL_1_PATHWAY_UP
0.00000 0.00000 0.00150NETPATH_IL_6_PATHWAY_UP
0.00000 0.00051 0.00032NCI_IL12_2PATHWAY
0.00000 0.00814 0.00029SA_MMP_CYTOKINE_CONNECTION
0.00000 0.00171 0.00030NETPATH_IL_3_PATHWAY_UP
0.00004 0.00856 0.00005NETPATH_IL_7_PATHWAY_UP
0.00020 0.00126 0.00440NCI_IL23PATHWAY
0.00116 0.00000 0.05794GERY_CEBP_TARGETS
0.00000 0.00000 0.00340NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.00000 0.05924NETPATH_IL_5_PATHWAY_UP
0.00000 0.01106 0.02314NETPATH_IL_4_PATHWAY_UP
0.00007 0.00067 0.01205NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.00000 0.00288 0.00014NCI_IL6_7PATHWAY
0.00007 0.01857 0.00065NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00000 0.00767 0.01520RICKMAN_METASTASIS_DN
0.00008 0.17296 0.00253TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.00101 0.00144 0.12462NCI_BCR_5PATHWAY
0.00547 0.00002 0.01105GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.02317 0.00001RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.00000 0.08229 0.00207NETPATH_IL_9_PATHWAY_UP
0.04046 0.03354 0.11374WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.00000 0.00120 0.00007LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00000 0.02321 0.00002KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00013 0.00035 0.00228VARELA_ZMPSTE24_TARGETS_UP
0.06758 0.06793 0.09678CORUM_ITGA2B-ITGB3-CD9_COMPLEX
0.01440 0.19448 0.18765FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.00000 0.00000 0.02223LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.01394 0.00118 0.06455BIOCARTA_IL1R_PATHWAY
0.00014 0.00000 0.00644KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00001 0.00000 0.09956RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00000 0.00009RADAEVA_RESPONSE_TO_IFNA1_UP
0.00089 0.15708 0.01520GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.00007 0.02836 0.00706LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.00005 0.15986 0.00740COATES_MACROPHAGE_M1_VS_M2_UP
0.00250 0.02313 0.07903VALK_AML_CLUSTER_1
0.00042 0.00000 0.15480AMIT_EGF_RESPONSE_40_HELA
0.00166 0.00000 0.00412BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.00032 0.00136 0.03458JEON_SMAD6_TARGETS_UP
0.00104 0.11340 0.01115NAKAYAMA_FRA2_TARGETS
0.03497 0.00000 0.14846MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.01879 0.00000MORI_MATURE_B_LYMPHOCYTE_UP
0.00174 0.00000 0.01294THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00039 0.10551 0.00819KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.00001 0.00000 0.06656TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.02771 0.09937 0.07782CONRAD_GERMLINE_STEM_CELL
0.00000 0.00000 0.00000LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00184 0.07983 0.04554BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.01320 0.03735 0.10012KUMAR_TARGETS_OF_MLL_AF9_FUSION
0.00001 0.00000 0.00058HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00000 0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.01765 0.00318 0.12897NCI_HIF1_TFPATHWAY
0.00053 0.00000 0.00156XU_AKT1_TARGETS_6HR
0.08277 0.10555 0.10032HUANG_FOXA2_TARGETS_UP
0.00000 0.01142 0.00000POOLA_INVASIVE_BREAST_CANCER_UP
0.00443 0.16162 0.18911SENGUPTA_EBNA1_ANTICORRELATED
0.00958 0.07524 0.17324TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.18217 0.00526 0.12764WOTTON_RUNX_TARGETS_UP
0.00000 0.00067 0.00000LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00352 0.01390 0.18413NIELSEN_SYNOVIAL_SARCOMA_DN
0.00000 0.00176 0.00023REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00000 0.00181SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00001 0.00000 0.00295DAUER_STAT3_TARGETS_DN
0.00031 0.00116 0.01422RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.00037 0.00000 0.00639AMIT_EGF_RESPONSE_120_HELA
0.00067 0.00880 0.18816DANG_REGULATED_BY_MYC_DN
0.00161 0.00299 0.07034FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00000 0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.00095 0.00298 0.00554PARK_TRETINOIN_RESPONSE
0.00028 0.00000 0.00465PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00000 0.00095 0.00018HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.00000 0.00097 0.00000JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.00007 0.00460 0.04573KYNG_DNA_DAMAGE_UP
0.00000 0.00014 0.00413LEE_LIVER_CANCER_E2F1_UP
0.00018 0.08818 0.01489DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.01106 0.00485 0.07165PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.00000 0.00000 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.00806 0.05406 0.00954ROETH_TERT_TARGETS_DN
0.00001 0.00000 0.00007BOWIE_RESPONSE_TO_TAMOXIFEN
0.02136 0.02415 0.16868NCI_P38ALPHABETAPATHWAY
0.00000 0.00021 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00000 0.07952 0.00253SMID_BREAST_CANCER_LUMINAL_B_DN
0.00012 0.00000 0.03822ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00337 0.00007 0.06018FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.01643 0.09475 0.03081NETPATH_IL_3_PATHWAY_DOWN
0.00000 0.02147 0.07784VANTVEER_BREAST_CANCER_ESR1_DN
0.00064 0.15494 0.04204STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.05936 0.06718 0.11413CORUM_ITGAV-ITGB8-MMP14-TGFB1_COMPLEX
0.00005 0.01587 0.00001REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00022 0.10884 0.00646REACTOME_TOLL_LIKE_RECEPTOR_4_CASCADE
0.00000 0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00000 0.00000 0.00011BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00009 0.06184 0.00508REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.00052 0.10331 0.00648REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.00000 0.17649 0.00000TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.12283 0.04454 0.03806SPIRA_SMOKERS_LUNG_CANCER_UP
0.00000 0.00000 0.02222TIAN_TNF_SIGNALING_VIA_NFKB
0.00000 0.00000 0.00866KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01955 0.03548 0.02336GOLUB_ALL_VS_AML_DN
0.00005 0.00023 0.00816LEE_EARLY_T_LYMPHOCYTE_DN
0.00020 0.01725 0.00092TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.00050 0.00205 0.17601CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00151 0.00000 0.00960HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00000 0.00002 0.04577CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00196 0.06127 0.18902NCI_ATF2_PATHWAY
0.00103 0.03373 0.02818KEGG_PRIMARY_IMMUNODEFICIENCY
0.00000 0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.02413 0.00060 0.09399COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN
0.00006 0.00030 0.00132STEARMAN_TUMOR_FIELD_EFFECT_UP
0.00000 0.00025 0.00903CROONQUIST_STROMAL_STIMULATION_UP
0.00016 0.04261 0.00818BOYLAN_MULTIPLE_MYELOMA_D_DN
0.00000 0.00000 0.00030KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00165 0.00065 0.14830KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.00017 0.00000 0.00144KIM_LRRC3B_TARGETS
0.06560 0.08089 0.07388DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.00059 0.00000 0.01757HORIUCHI_WTAP_TARGETS_UP
0.00000 0.00002 0.05653WOO_LIVER_CANCER_RECURRENCE_UP
0.00000 0.07142 0.10547NETPATH_B_CELL_RECEPTOR_PATHWAY
0.00000 0.00000 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.08699 0.16621 0.10543DORN_ADENOVIRUS_INFECTION_32HR_UP
0.00009 0.13686 0.01423BIOCARTA_TH1TH2_PATHWAY
0.00356 0.00004 0.00743TSAI_DNAJB4_TARGETS_UP
0.00003 0.00014 0.00033MORI_PRE_BI_LYMPHOCYTE_DN
0.00944 0.17578 0.03537BOQUEST_STEM_CELL_DN
0.00214 0.00000 0.08872DER_IFN_BETA_RESPONSE_UP
0.00056 0.00000 0.00766DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00330 0.02112 0.14278GARY_CD5_TARGETS_UP
0.00141 0.06095 0.08394GILDEA_METASTASIS
0.00184 0.00486 0.00673AMIT_EGF_RESPONSE_20_HELA
0.00000 0.00000 0.00734TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.00000 0.00000 0.00000BASSO_CD40_SIGNALING_UP
0.14706 0.00063 0.01296BIOCARTA_NTHI_PATHWAY
0.00264 0.00011 0.02313TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00357 0.18427 0.04397IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
0.01034 0.04578 0.08859BIOCARTA_FCER1_PATHWAY
0.00004 0.00127 0.04723MARZEC_IL2_SIGNALING_UP
0.00000 0.00000 0.00351NAGASHIMA_NRG1_SIGNALING_UP
0.00448 0.04300 0.00468BIOCARTA_BLYMPHOCYTE_PATHWAY
0.00486 0.11635 0.18888LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.00000 0.02453 0.00000BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.11589 0.04554 0.13115ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00010 0.00019 0.15201WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.00628 0.00067 0.08258FRIDMAN_SENESCENCE_UP
0.00001 0.00004 0.00131MAHADEVAN_RESPONSE_TO_MP470_UP
0.00000 0.15473 0.00000SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.00156 0.00018 0.18558FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00000 0.00000 0.00245SANA_RESPONSE_TO_IFNG_UP
0.00466 0.00534 0.08743ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00000 0.00007 0.00000KEGG_LEISHMANIA_INFECTION
0.01167 0.01228 0.18458REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.00000 0.07526 0.00000BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.00291 0.00006 0.02231CHEN_HOXA5_TARGETS_9HR_UP
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00635 0.00420 0.03894HOEBEKE_LYMPHOID_STEM_CELL_UP
0.00003 0.00000 0.00022GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00001 0.00026 0.00521PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.00000 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.00000 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00252 0.10630 0.00506BIOCARTA_ASBCELL_PATHWAY
0.00000 0.00016 0.00000RODWELL_AGING_KIDNEY_UP
0.00067 0.00015 0.04273REACTOME_TOLL_RECEPTOR_CASCADES
0.00111 0.12410 0.01560INGA_TP53_TARGETS
0.00022 0.00736 0.02393ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00252 0.00059 0.05665KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00034 0.00925 0.00142VALK_AML_CLUSTER_5
0.00000 0.00002 0.00000MORI_IMMATURE_B_LYMPHOCYTE_UP
0.00973 0.14568 0.18433REACTOME_ACTIVATED_TLR4_SIGNALLING
0.00000 0.00000 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00000 0.00175 0.00000CROONQUIST_NRAS_SIGNALING_UP
0.00947 0.00018 0.13805BIOCARTA_TOLL_PATHWAY
0.01342 0.01895 0.17711IIZUKA_RECURRENT_LIVER_CANCER
0.02221 0.15010 0.11427NCI_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.00265 0.00000 0.10357OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00001 0.00002 0.03067BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.00473 0.00000 0.06352RUTELLA_RESPONSE_TO_HGF_UP
0.00000 0.07998 0.00243HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.00099 0.00000 0.12936PRAMOONJAGO_SOX4_TARGETS_UP
0.00107 0.00000 0.01248PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.04364 0.03057 0.01294YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.08863 0.14130 0.17907MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.00075 0.04654 0.06829VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.00285 0.02320 0.13171BIOCARTA_PML_PATHWAY
0.00000 0.00000 0.00011TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00000 0.00000 0.00069BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.00000 0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.04103 0.06690 0.11487SWEET_LUNG_CANCER_KRAS_UP
0.00000 0.13556 0.00032TENEDINI_MEGAKARYOCYTE_MARKERS
0.01382 0.00015 0.02396CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.01520 0.00691 0.14982HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.00526 0.13568 0.03083CORUM_ITGA2B-ITGB3-CD9-GP1B-CD47_COMPLEX
0.00000 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00000 0.01956 0.00000MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.00033 0.03785 0.00550WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.02739 0.05325 0.03802YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00002 0.00137 0.00035BIOCARTA_NKT_PATHWAY
0.00000 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00000 0.00035 0.00000WILENSKY_RESPONSE_TO_DARAPLADIB
0.00000 0.00004 0.00007TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.00184 0.07823 0.03334HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.00000 0.00051 0.00032REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00022 0.00015 0.00140ROETH_TERT_TARGETS_UP
0.05819 0.00089 0.15168FRIDMAN_IMMORTALIZATION_DN
0.00000 0.00060 0.00966KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00002 0.00021 0.00584OSADA_ASCL1_TARGETS_DN
0.02045 0.00470 0.11079REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.00068 0.18330 0.00168BIOCARTA_LYM_PATHWAY
0.00144 0.00000 0.11368NUYTTEN_EZH2_TARGETS_UP
0.00000 0.00002 0.00023DUTTA_APOPTOSIS_VIA_NFKB
0.00000 0.07867 0.00142PARK_APL_PATHOGENESIS_DN
0.00000 0.00008 0.05204TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00000 0.00018 0.02216DELYS_THYROID_CANCER_UP
0.00000 0.00000 0.00342DIRMEIER_LMP1_RESPONSE_EARLY
0.00181 0.00469 0.08853KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.02278 0.04672 0.10625SEMENZA_HIF1_TARGETS
0.00000 0.00000 0.00011BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00163 0.04074 0.00283ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.00039 0.00002 0.05362ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00006 0.00000 0.00908RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00507 0.10086 0.16184ONDER_CDH1_TARGETS_3_DN
0.00000 0.02077 0.00458TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.00000 0.00000 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00000 0.00002 0.00000LIAN_LIPA_TARGETS_6M
0.00276 0.02002 0.04791NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.13241 0.00000 0.13532BROWNE_HCMV_INFECTION_8HR_UP
0.00041 0.19447 0.08026NCI_CD8TCRPATHWAY
0.00000 0.17320 0.00000RAMALHO_STEMNESS_DN
0.00085 0.00011 0.04493TAVOR_CEBPA_TARGETS_UP
0.00000 0.00000 0.00078FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.00000 0.00000 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00070 0.00000 0.00730GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.04099 0.00117 0.09089SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00161 0.00092 0.19454PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.00000 0.01556 0.00116MARKEY_RB1_CHRONIC_LOF_DN
0.00002 0.09678 0.01327NCI_AMB2_NEUTROPHILS_PATHWAY
0.00032 0.00002 0.00164GESERICK_TERT_TARGETS_DN
0.00758 0.00051 0.04856NOJIMA_SFRP2_TARGETS_DN
0.00014 0.03737 0.05666KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00009 0.00013 0.00533AMIT_SERUM_RESPONSE_120_MCF10A
0.05336 0.00294 0.13916TAVOR_CEBPA_TARGETS_DN
0.00000 0.00022 0.00544LEE_LIVER_CANCER_MYC_E2F1_UP
0.06247 0.01300 0.08937NCI_IL1PATHWAY
0.01412 0.00000 0.11456SESTO_RESPONSE_TO_UV_C3
0.03686 0.19726 0.02855TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.00022 0.00000 0.01274GEISS_RESPONSE_TO_DSRNA_UP
0.00030 0.00000 0.00118GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00050 0.00666 0.17607SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.04195 0.16209 0.10029BIOCARTA_TCAPOPTOSIS_PATHWAY
0.00031 0.00065 0.00053GRANDVAUX_IRF3_TARGETS_UP
0.00083 0.00000 0.06440ZHU_CMV_ALL_UP
0.00259 0.00007 0.15176ROZANOV_MMP14_TARGETS_UP
0.08675 0.00485 0.11926NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.00011 0.13990 0.02333LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000 0.01422NAGASHIMA_EGF_SIGNALING_UP
0.00003 0.00496 0.01788REACTOME_TCR_SIGNALING
0.00184 0.06667 0.01050KEGG_TYPE_I_DIABETES_MELLITUS
0.00070 0.00004 0.06686AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.00225 0.00077KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00170 0.00003 0.00739RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.01388 0.00079 0.13502CHEN_HOXA5_TARGETS_6HR_UP
0.00301 0.00000 0.09755OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00000 0.00000 0.00642SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00008 0.01105 0.02395LEONARD_HYPOXIA
0.00085 0.11442 0.09105MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.05593 0.04926 0.12404CORUM_ITGA2B-ITGB3-CD47-FAK_COMPLEX
0.00000 0.00029 0.02710LEE_LIVER_CANCER_MYC_TGFA_UP
0.00729 0.18861 0.02298NCI_TOLL_LIKE_RECEPTOR_4__TLR4__CASCADE
0.00000 0.01367 0.00857LEE_LIVER_CANCER_DENA_UP
0.00175 0.01212 0.03077HALMOS_CEBPA_TARGETS_UP
0.00166 0.02779 0.18457WU_CELL_MIGRATION
0.00855 0.00294 0.01729YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.00000 0.00000 0.00209TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00000 0.00000 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.00451 0.00000 0.07135SAGIV_CD24_TARGETS_DN
0.00447 0.14697 0.11463REACTOME_MYD88_CASCADE
0.00443 0.08402 0.19862KEGG_MAPK_SIGNALING_PATHWAY
0.00000 0.00000 0.00000WIELAND_UP_BY_HBV_INFECTION
0.00022 0.02011 0.00268COATES_MACROPHAGE_M1_VS_M2_DN
0.02715 0.01382 0.03335GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.01539 0.11957 0.09374EHRLICH_ICF_SYNDROM_DN
0.00001 0.00000 0.00027UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00000 0.00000 0.00004TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00025 0.00067 0.03906HARRIS_HYPOXIA
0.00000 0.00000 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.00156 0.00577 0.02975CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.00000 0.10198 0.02458REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.00826 0.00218 0.14075REACTOME_INNATE_IMMUNITY_SIGNALING
0.00136 0.12876 0.01572WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.01034 0.00571 0.19460KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00000 0.00089 0.00000DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.00005 0.19466 0.01567NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00274 0.02074 0.00430XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.00027 0.02521 0.00038SOUCEK_MYC_TARGETS
0.01086 0.00228 0.08988TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00005 0.01866 0.00006BILBAN_B_CLL_LPL_DN
0.00002 0.00317 0.01548KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00408 0.00047 0.06495IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.02277 0.04209 0.05201CORUM_ITGA2B-ITGB3-CD47-SRC_COMPLEX
0.00000 0.00000 0.00081ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00607 0.00343 0.08016KEGG_AUTOIMMUNE_THYROID_DISEASE
0.00101 0.00137 0.09163TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.00000 0.00012 0.00000FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.00024 0.00000 0.05938BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00000 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00307 0.00000 0.06350DAUER_STAT3_TARGETS_UP
0.00592 0.15639 0.07782NETPATH_KIT_RECEPTOR_PATHWAY
0.00122 0.00000 0.09673DER_IFN_ALPHA_RESPONSE_UP
0.00000 0.00473 0.05856LEE_LIVER_CANCER_ACOX1_UP
0.00000 0.00287 0.00008RUTELLA_RESPONSE_TO_HGF_DN
0.02738 0.00139 0.07674WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.00358 0.08977 0.12473BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.03269 0.00008 0.02827ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00111 0.01541 0.05324DAZARD_UV_RESPONSE_CLUSTER_G2
0.00004 0.00000 0.00290EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00000 0.00001 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.00064 0.02873 0.14378ST_T_CELL_SIGNAL_TRANSDUCTION
0.00014 0.00549 0.00019KEGG_ALLOGRAFT_REJECTION
0.00005 0.00000 0.03677AMIT_SERUM_RESPONSE_40_MCF10A
0.14521 0.15010 0.16098DE_YY1_TARGETS_UP
0.01785 0.00024 0.07524BROWNE_HCMV_INFECTION_4HR_UP
0.00000 0.00000 0.00059ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.00000 0.00029ZHU_CMV_8_HR_UP
0.00411 0.14258 0.11915MARSON_FOXP3_TARGETS_DN
0.00595 0.05068 0.02390BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000 0.00008SANA_TNF_SIGNALING_UP
0.00084 0.00000 0.00351TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00085 0.04704 0.13686THUM_SYSTOLIC_HEART_FAILURE_UP
0.00004 0.04359 0.03237NCI_IL27PATHWAY
0.00000 0.00036 0.00142SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.01080 0.01303 0.03587SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00003 0.00300 0.00033TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.02073 0.11732 0.10201REACTOME_PECAM1_INTERACTIONS
0.00000 0.00283 0.00397ROSS_AML_WITH_CBFB_MYH11_FUSION
0.00223 0.00001 0.02953XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00036 0.00500 0.03586ONDER_CDH1_TARGETS_2_DN
0.01212 0.04663 0.01434NAKAJIMA_MAST_CELL
0.00260 0.00316 0.00715CASTELLANO_NRAS_TARGETS_UP
0.00004 0.00000 0.02652HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.01268 0.09556 0.13207LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.00000 0.11260 0.00000KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.00974 0.04041 0.09153SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.02396 0.00552 0.17909SENESE_HDAC3_TARGETS_UP
0.00007 0.16692 0.02332NCI_PI3KCIPATHWAY
0.00000 0.00000 0.00000LIAN_LIPA_TARGETS_3M
0.00000 0.02902 0.00209KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00001 0.03083 0.00002KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.00000 0.01103 0.15226CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.03830 0.01288 0.03642FUJII_YBX1_TARGETS_UP
0.00336 0.00000 0.10221UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00063 0.00239 0.09161XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00000 0.00000 0.00099JISON_SICKLE_CELL_DISEASE_UP
0.10024 0.13973 0.12445BAELDE_DIABETIC_NEPHROPATHY_DN
0.00001 0.13077 0.00901NCI_IL12_STAT4PATHWAY
0.01035 0.00022 0.00033CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.00001 0.00469 0.07602XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.01174 0.12091 0.15930NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.00974 0.01942 0.08712HELLER_HDAC_TARGETS_DN
0.00009 0.00002 0.00033GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00531 0.10077 0.01657BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.00000 0.00952 0.05935ZHAN_MULTIPLE_MYELOMA_HP_UP
0.00899 0.00039 0.05374ZUCCHI_METASTASIS_DN
0.00009 0.02153 0.00508LU_IL4_SIGNALING
0.00007 0.00812 0.00554DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.00000 0.01462 0.00837HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.00053 0.04119 0.10584IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.01564 0.00504 0.14680OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP
0.01382 0.04327 0.07019WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.06622 0.04989 0.10014FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP